APA (7th ed.) Citation

M, B., T, H., L, A., T, C., P, C., T, F., . . . J, S. (2025). Cost-effectiveness of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression: Economic evaluation of the PAX-BD randomised controlled trial. Journal of affective disorders, 391, 119937. https://doi.org/10.1016/j.jad.2025.119937

Chicago Style (17th ed.) Citation

M, Berger, et al. "Cost-effectiveness of Pramipexole in Addition to Mood Stabilisers for Patients with Treatment-resistant Bipolar Depression: Economic Evaluation of the PAX-BD Randomised Controlled Trial." Journal of Affective Disorders 391 (2025): 119937. https://doi.org/10.1016/j.jad.2025.119937.

MLA (9th ed.) Citation

M, Berger, et al. "Cost-effectiveness of Pramipexole in Addition to Mood Stabilisers for Patients with Treatment-resistant Bipolar Depression: Economic Evaluation of the PAX-BD Randomised Controlled Trial." Journal of Affective Disorders, vol. 391, 2025, p. 119937, https://doi.org/10.1016/j.jad.2025.119937.